Biblio

] Title Type Year

Filters: First Letter Of Last Name is T [Clear All Filters]

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

T

Turner EC, Huang CL, Sawhney N, Govindarajan K, Clover AJP, Martin K, Browne TC, Kumar AHS, Mackrill JJ, Whelan D, et al. A novel selectable ISL-1 positive progenitor cell reprogrammed to expandable and functional smooth muscle cells. Stem Cells. 2016.

Turner DA, Trott J, Hayward P, Rué P, Arias AMartinez. An interplay between extracellular signalling and the dynamics of the exit from pluripotency drives cell fate decisions in mouse ES cells. Biol Open. 2014.

Turner J, Quek L-E, Titmarsh D, Krömer JO, Kao L-P, Nielsen L, Wolvetang E, Cooper-White J. Metabolic Profiling and Flux Analysis of MEL-2 Human Embryonic Stem Cells during Exponential Growth at Physiological and Atmospheric Oxygen Concentrations. PLoS One. 2014;9(11):e112757.

Turner SA, Wright KT, Jones PN, Balain B, Roberts S. Temporal Analyses of the Response of Intervertebral Disc Cells and Mesenchymal Stem Cells to Nutrient Deprivation. Stem Cells Int. 2016;2016:5415901.

Turner L, Munsie M, Levine AD, Ikonomou L. Ethical issues and public communication in the development of cell-based treatments for COVID-19: Lessons from the pandemic. Stem Cell Reports. 2021.

Turner L. The American stem cell sell in 2021: U.S. businesses selling unlicensed and unproven stem cell interventions. Cell Stem Cell. 2021;28(11):1891-1895.

Turner L, Martinez JRamon, Najjar S, Arachchilage TRajapaksha, Sahrai V, Wang JChieng. Safety and efficacy claims made by US businesses marketing purported stem cell treatments and exosome therapies. Regen Med. 2023.

Turnbull IC, Karakikes I, Serrao GW, Backeris P, Lee J-J, Xie C, Senyei G, Gordon RE, Li RA, Akar FG, et al. Advancing functional engineered cardiac tissues toward a preclinical model of human myocardium. FASEB J. 2013.

Turlo AJ, Hammond DE, Ramsbottom KA, Soul J, Gillen A, McDonald K, Peffers MJ. Mesenchymal Stromal Cell secretome is affected by tissue source and donor age. Stem Cells. 2023.

Turlo KA, Scapa J, Bagher P, Jones AW, Feil R, Korthuis RJ, Segal SS, M Iruela-Arispe L. β1-Integrin Is Essential for Vasoregulation and Smooth Muscle Survival In Vivo. Arterioscler Thromb Vasc Biol. 2013.

Turlinskienė M, Seniūnaitė-Ramanauskienė R, Pociūnaitė J, Sargautytė R. Psychological empowerment and quality of life in haematopoietic stem cell transplantation patients: A quantitative study. Nurs Open. 2023.

Türkuçar S, Bülbül G, Ünsal E, Özer E, Erdağ TKemal, Erkoç E, Makay B. Exploring the immunological basis of periodic fever, aphthous stomatitis, pharyngitis, and adenitis (PFAPA) syndrome: immunohistochemical staining features of palatine tonsils. Clin Rheumatol. 2023.

Turksen K. All about claudins. Tissue Barriers. 2013;1(3):e26750.

Turksen K. Preface. Stem Cell Renewal and Cell-Cell Communication. Methods Mol Biol. 2015;1212:v.

Turksen K. Preface. Human Embryonic Stem Cell Protocols. Methods Mol Biol. 2016;1307:v.

Turkova T, Kokavec J, Zikmund T, Dibus N, Pimková K, Nemec D, Holeckova M, Ruskova L, Sedlacek R, Cermak L, et al. Differential requirements for Smarca5 expression during hematopoietic stem cell commitment. Commun Biol. 2024;7(1):244.

Turkina A, Wang J, Mathews V, Saydam G, Jung CWon, Hashmi HHassan Al, Yassin M, Le Clanche S, Miljkovic D, Slader C, et al. TARGET: a survey of real-world management of chronic myeloid leukaemia across 33 countries. Br J Haematol. 2020.

Turki AT, Klisanin V, Bayraktar E, Kordelas L, Trenschel R, Ottinger H, Steckel NK, Tsachakis-Mück N, Leserer S, Ditschkowski M, et al. Optimizing anti-T-lymphocyte globuline dosing to improve long-term outcome after unrelated hematopoietic cell transplantation for hematologic malignancies. Am J Transplant. 2019.

Turki AT, Lamm W, Schmitt C, Bayraktar E, Alashkar F, Metzenmacher M, Wohlfarth P, Beelen DW, Liebregts T. Correction to: Platelet number and graft function predict intensive care survival in allogeneic stem cell transplantation patients. Ann Hematol. 2018.

Turki AT, Tsachakis-Mück N, Leserer S, Crivello P, Liebregts T, Betke L, Alashkar F, Leimkühler NBastian, Trilling M, Fleischhauer K, et al. Impact of CMV reactivation on relapse of acute myeloid leukemia after HCT is dependent on disease stage and ATG. Blood Adv. 2021.

Turkekul K, Erdogan S. Potent Suppression of Prostate Cancer Cell Growth and Eradication of Cancer Stem Cells by CD44-targeted Nanoliposome-quercetin Nanoparticles. J Cancer Prev. 2023;28(4):160-174.

Türkantoz H, Königs C, Knöbl P, Klamroth R, Holstein K, Huth-Kühne A, Heinz J, Eichler H, Tiede A. Cross-reacting Inhibitors Against Recombinant Porcine Factor VIII in Acquired Hemophilia A: Data from the GTH-AH 01/2010 Study. J Thromb Haemost. 2019.

Turkalj B, Quallich D, Bessert DA, Kramer AC, Cook TA, Thummel R. Development and characterization of a chronic photoreceptor degeneration model in adult zebrafish that does not trigger a regenerative response. Exp Eye Res. 2021:108630.

Turk OM, Woodall RC, Gutova M, Brown CE, Rockne RC, Munson JM. Delivery strategies for cell-based therapies in the brain: overcoming multiple barriers. Drug Deliv Transl Res. 2021.

Turinetto V, Giachino C. Histone variants as emerging regulators of embryonic stem cell identity. Epigenetics. 2015;10(7):563-573.

Pages